Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertindole vs Olanzapine for Neurocognition in Schizophrenia
NCT00759421Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Oct 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sertindole in schizophrenia, sponsored by Lundbeck. Primary endpoint: Global cognitive composite score at 12 weeks. Started Oct 2006; status: completed.
02
Drugs
sertindole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00759421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759421.